Vericel Corporation (VCEL) is a publicly traded Healthcare sector company. As of November 5, 2026, VCEL trades at $45.48 with a market cap of $2.10B and a P/E ratio of 83.60. VCEL moved -0.01% today. Year to date, VCEL is +22.64%; over the trailing twelve months it is +25.45%. Its 52-week range spans $28.95 to $49.32. Analyst consensus is strong buy with an average price target of $56.33. Rallies surfaces VCEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Vericel Corporation (VCEL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VCEL moved -0.01% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $45.48 |
| Market Cap | $2.10B |
| P/E Ratio | 83.60 |
| EPS | $0.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.32 |
| 52-Week Low | $28.95 |
| Volume | 1.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $306.30M |
| Net Income | $24.22M |
| Gross Margin | 74.56% |
3 analysts cover VCEL: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $56.33.